The global POP Treatment and Management / Pelvic Organ Prolapse market is projected to reach USD 1.06 billion by 2030 from USD 0.77 billion in 2025, at a CAGR of 6.6% during the forecast period.
The market is expected to witness high growth due to the high global prevalence of pelvic organ prolapse, rising geriatric female population, growing awareness and early diagnosis, and advancements in minimally invasive and robotic surgical techniques. Complications and recalls associated with vaginal mesh, limited access and affordability in developing markets, underdiagnosis due to social stigma, and the risk of POP products are likely to restrain market growth.
“The hospitals segment of the POP Treatment and Management / Pelvic Organ Prolapse market, by end user, is expected to hold the largest position during the forecast period.”
Based on end user, the market is segmented into hospitals, specialty clinics, ambulatory surgery centers (ASCs), and others. In 2024, hospitals and clinics accounted for the largest share of the market. Hospitals benefit from centralized procurement systems, allowing for efficient integration of new POP technologies. Their access to government or institutional funding also facilitates the acquisition of expensive devices, such as robotic surgical systems, which may not be feasible in smaller outpatient facilities. Furthermore, hospitals are often the only facilities equipped to manage intraoperative complications, complex reconstructions, and comorbid conditions in elderly patients—ensuring their continued dominance in the pelvic organ prolapse treatment landscape.
“The surgical segment accounted for the larger market share in the POP Treatment and Management / Pelvic Organ Prolapse market.”
The POP Treatment and Management / Pelvic Organ Prolapse market is segmented into surgical and non-surgical. The surgical segment accounted for the larger share of the market in 2024. Surgical intervention is often preferred in cases involving multiple-compartment prolapses or associated conditions like stress urinary incontinence. Moreover, with the growing availability of minimally invasive and robotic-assisted methods, surgical options now offer quicker recovery and reduced postoperative complications, making them more acceptable to both patients and clinicians. Continuous innovation in surgical meshes, biologic grafts, and energy-assisted dissection tools further enhances procedural outcomes. Importantly, surgical treatments are backed by strong clinical guidelines and are often the first-line recommendation in moderate to severe POP, reinforcing their dominant position in the market.
“Asia Pacific is the fastest-growing market for POP Treatment and Management / Pelvic Organ Prolapse.”
The global POP Treatment and Management / Pelvic Organ Prolapse market is segmented into five segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is experiencing rapid population aging, especially in countries like China and Japan, leading to a rising incidence of pelvic organ prolapse disorders among elderly women. Increasing awareness of women’s health and growing acceptance of pelvic floor treatments are driving higher diagnosis and treatment rates. Governments across the region are investing in healthcare infrastructure, expanding access to surgical facilities, and supporting the adoption of advanced medical technologies, including robotic-assisted procedures. The rise of medical tourism in countries such as India and South Korea further fuels market growth, offering high-quality care at lower costs. While access disparities and a shortage of trained specialists still exist in rural areas, ongoing investments in healthcare training, digital health platforms, and public awareness campaigns are helping to close these gaps, positioning Asia Pacific as the fastest-growing regional market.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
• By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
• By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the POP Treatment and Management / Pelvic Organ Prolapse market are Boston Scientific Corporation (US), Coloplast Group (Denmark), Intuitive Surgical Operations, Inc. (US), CooperCompanies (US), and Johnson & Johnson (US).
Research Coverage
This report studies the POP Treatment and Management / Pelvic Organ Prolapse market based on product, treatment, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them to garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights into the following pointers:
Analysis of key drivers (High global prevalence of pelvic organ prolapse, rising geriatric female population, growing awareness and early diagnosis, and advancements in minimally invasive and robotic surgical techniques), restraints (complications and recalls associated with vaginal mesh, limited access and affordability in developing market, and underdiagnosis due to social stigma), opportunities (growth opportunities in emerging economies, development of bioengineered and absorbable mesh and digital health and pelvic floor therapy devices), and challenges (inconsistent clinical guidelines and treatment standards, and high recurrence and reoperation rates)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the POP Treatment and Management / Pelvic Organ Prolapse market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the POP Treatment and Management / Pelvic Organ Prolapse market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the POP Treatment and Management / Pelvic Organ Prolapse market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
圖表清單 List of Tables & Figures
TABLE 1 POPULATION OF FEMALES AGED 50 AND ABOVE, 2024 56
TABLE 2 AVERAGE SELLING PRICING TREND OF PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION PRODUCTS, BY TYPE, 2023–2025 62
TABLE 3 AVERAGE SELLING PRICE TREND OF PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION PRODUCTS, BY TREATMENT AND KEY PLAYER, 2023–2025 62
TABLE 4 AVERAGE SELLING PRICE TREND OF PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION PRODUCTS, BY REGION, 2023–2025 63
TABLE 5 ROLE OF COMPANIES IN ECOSYSTEM 67
TABLE 6 PATENT ANALYSIS 71
TABLE 7 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 72
TABLE 8 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 73
TABLE 9 KEY CONFERENCES AND EVENTS, 2025–2026 73
TABLE 10 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 77
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 16 IMPACT OF PORTER’S FIVE FORCES ON PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET 81
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
TOP FOUR PRODUCTS (%) 83
TABLE 18 KEY BUYING CRITERIA FOR TOP FOUR PRODUCTS 83
TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 87
TABLE 20 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 91
TABLE 21 KEY PRODUCTS IN SYNTHETIC MESH MARKET 92
TABLE 22 SYNTHETIC MESH SALES, BY COUNTRY, 2023–2030 (UNITS) 92
TABLE 23 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY REGION, 2023–2030 (USD MILLION) 93
TABLE 24 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY COUNTRY, 2023–2030 (USD MILLION) 93
TABLE 25 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 26 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 27 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SYNTHETIC MESH, BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 28 KEY PRODUCTS IN BIOLOGICAL GRAFTS MARKET 96
TABLE 29 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR BIOLOGICAL GRAFTS, BY REGION, 2023–2030 (USD MILLION) 96
TABLE 30 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR BIOLOGICAL GRAFTS, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 31 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR BIOLOGICAL GRAFTS, BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 32 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR BIOLOGICAL GRAFTS, BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 33 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR BIOLOGICAL GRAFTS, BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 34 KEY PRODUCTS IN SUTURES MARKET 98
TABLE 35 SUTURE SALES, BY COUNTRY, 2023–2030 (UNITS) 99
TABLE 36 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY REGION, 2023–2030 (USD MILLION) 99
TABLE 37 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 38 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 39 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 40 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SUTURES, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 41 KEY PRODUCTS IN VAGINAL PESSARIES MARKET 102
TABLE 42 VAGINAL PESSARY SALES, BY COUNTRY, 2023–2030 (UNITS) 103
TABLE 43 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY REGION, 2023–2030 (USD MILLION) 103
TABLE 44 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 45 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 46 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 47 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARIES, BY COUNTRY, 2022–2030 (USD MILLION) 105
TABLE 48 KEY PRODUCTS IN PELVIC FLOOR THERAPY DEVICES MARKET 106
TABLE 49 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY REGION, 2023–2030 (USD MILLION) 107
TABLE 50 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY COUNTRY,
2023–2030 (USD MILLION) 107
TABLE 51 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 52 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY COUNTRY,
2023–2030 (USD MILLION) 108
TABLE 53 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR THERAPY DEVICES, BY COUNTRY,
2023–2030 (USD MILLION) 109
TABLE 54 KEY PRODUCTS IN ROBOTIC SURGERY SYSTEMS MARKET 109
TABLE 55 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 110
TABLE 56 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 57 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 58 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 59 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ROBOTIC SURGERY SYSTEMS, BY COUNTRY,
2023–2030 (USD MILLION) 112
TABLE 60 KEY PRODUCTS IN DIAGNOSTIC & ASSESSMENT TOOLS MARKET 113
TABLE 61 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 62 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY COUNTRY,
2023–2030 (USD MILLION) 113
TABLE 63 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 64 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 65 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR DIAGNOSTIC & ASSESSMENT TOOLS, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 66 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 117
TABLE 67 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY TYPE, 2023–2030 (USD MILLION) 118
TABLE 68 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 69 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 70 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 119
TABLE 71 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 72 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 120
TABLE 73 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPOCLEISIS, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 74 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPOCLEISIS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 75 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPOCLEISIS, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 76 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR COLPOCLEISIS, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 77 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPOCLEISIS, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 78 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY REGION, 2023–2030 (USD MILLION) 124
TABLE 79 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 80 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 81 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 82 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR COLPORRHAPY, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 83 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY REGION, 2023–2030 (USD MILLION) 127
TABLE 84 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 85 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 86 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 87 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROCOLPOPEXY, BY COUNTRY, 2022–2030 (USD MILLION) 129
TABLE 88 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY REGION, 2023–2030 (USD MILLION) 130
TABLE 89 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 90 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 91 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 92 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SACROHYSTEROPEXY, BY COUNTRY, 2022–2030 (USD MILLION) 132
TABLE 93 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION, BY REGION,
2023–2030 (USD MILLION) 133
TABLE 94 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION,
BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 95 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION, BY COUNTRY,
2023–2030 (USD MILLION) 134
TABLE 96 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION,
BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 97 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTEROSACRAL OR SACROSPINOUS LIGAMENT FIXATION,
BY COUNTRY, 2022–2030 (USD MILLION) 135
TABLE 98 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR
NON-SURGICAL, BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 99 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR
NON-SURGICAL, BY REGION, 2023–2030 (USD MILLION) 136
TABLE 100 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 101 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 102 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 103 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR NON-SURGICAL, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 104 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARY MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 105 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARY MANAGEMENT, BY COUNTRY,
2023–2030 (USD MILLION) 140
TABLE 106 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARY MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 107 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR VAGINAL PESSARY MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 108 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR VAGINAL PESSARY MANAGEMENT, BY COUNTRY,
2023–2030 (USD MILLION) 141
TABLE 109 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY REGION, 2023–2030 (USD MILLION) 142
TABLE 110 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY COUNTRY,
2023–2030 (USD MILLION) 143
TABLE 111 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 112 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 113 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR PELVIC FLOOR MUSCLE THERAPY, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 114 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 146
TABLE 115 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY REGION, 2023–2030 (USD MILLION) 147
TABLE 116 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 117 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 118 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 119 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR CYSTOCELE, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 120 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR URETHROCELE, BY REGION, 2023–2030 (USD MILLION) 150
TABLE 121 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR URETHROCELE, BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 122 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR URETHROCELE, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 123 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR URETHROCELE, BY COUNTRY, 2023–2030 (USD MILLION) 151
TABLE 124 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR URETHROCELE, BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 125 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY REGION, 2023–2030 (USD MILLION) 153
TABLE 126 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 127 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 128 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 129 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR ENTEROCELE, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 130 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY REGION, 2023–2030 (USD MILLION) 156
TABLE 131 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 132 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 133 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 134 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR UTERINE PROLAPSE, BY COUNTRY, 2022–2030 (USD MILLION) 158
TABLE 135 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY REGION, 2023–2030 (USD MILLION) 159
TABLE 136 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 137 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 138 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 139 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR RECTOCELE, BY COUNTRY, 2023–2030 (USD MILLION) 161
TABLE 140 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 163
TABLE 141 HOSPITALS PER CAPITA, BY COUNTRY, 2024 164
TABLE 142 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 165
TABLE 143 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 144 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 145 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 146 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 147 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SPECIALTY CLINICS, BY REGION, 2023–2030 (USD MILLION) 168
TABLE 148 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 149 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 150 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 151 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 152 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION) 171
TABLE 153 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY,
2023–2030 (USD MILLION) 171
TABLE 154 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 155 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY,
2023–2030 (USD MILLION) 172
TABLE 156 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY,
2023–2030 (USD MILLION) 173
TABLE 157 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 174
TABLE 158 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 159 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 160 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 161 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 176
TABLE 162 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY REGION, 2023–2030 (USD MILLION) 178
TABLE 163 NORTH AMERICA: MACROECONOMIC INDICATORS 179
TABLE 164 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181
TABLE 165 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 181
TABLE 166 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 182
TABLE 167 NORTH AMERICA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 182
TABLE 168 NORTH AMERICA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 169 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 183
TABLE 170 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 184
TABLE 171 US: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 185
TABLE 172 US: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 185
TABLE 173 US: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 174 US: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 175 US: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 187
TABLE 176 US: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 187
TABLE 177 CANADA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188
TABLE 178 CANADA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 189
TABLE 179 CANADA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 180 CANADA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 181 CANADA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 190
TABLE 182 CANADA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 191
TABLE 183 EUROPE: MACROECONOMIC INDICATORS 192
TABLE 184 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 192
TABLE 185 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 193
TABLE 186 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 193
TABLE 187 EUROPE: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 188 EUROPE: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 194
TABLE 189 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 195
TABLE 190 EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 195
TABLE 191 GERMANY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196
TABLE 192 GERMANY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 197
TABLE 193 GERMANY: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 194 GERMANY: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 195 GERMANY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 198
TABLE 196 GERMANY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 199
TABLE 197 FRANCE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 200
TABLE 198 FRANCE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 200
TABLE 199 FRANCE: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 200 FRANCE: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 201 FRANCE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 202
TABLE 202 FRANCE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 202
TABLE 203 UK: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 204
TABLE 204 UK: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 204
TABLE 205 UK: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 206 UK: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 207 UK: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 206
TABLE 208 UK: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 206
TABLE 209 ITALY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 208
TABLE 210 ITALY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 208
TABLE 211 ITALY: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 212 ITALY: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 213 ITALY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 210
TABLE 214 ITALY: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 210
TABLE 215 SPAIN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 211
TABLE 216 SPAIN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 212
TABLE 217 SPAIN: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 218 SPAIN: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 219 SPAIN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 213
TABLE 220 SPAIN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 214
TABLE 221 REST OF EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 215
TABLE 222 REST OF EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 215
TABLE 223 REST OF EUROPE: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 216
TABLE 224 REST OF EUROPE: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 216
TABLE 225 REST OF EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 217
TABLE 226 REST OF EUROPE: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 217
TABLE 227 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 219
TABLE 228 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 220
TABLE 229 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 220
TABLE 230 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 221
TABLE 231 ASIA PACIFIC: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 232 ASIA PACIFIC: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 233 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 222
TABLE 234 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 223
TABLE 235 CHINA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 224
TABLE 236 CHINA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 224
TABLE 237 CHINA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 238 CHINA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 239 CHINA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 226
TABLE 240 CHINA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 226
TABLE 241 JAPAN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 228
TABLE 242 JAPAN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 228
TABLE 243 JAPAN: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 244 JAPAN: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 245 JAPAN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 230
TABLE 246 JAPAN: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 230
TABLE 247 INDIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 232
TABLE 248 INDIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 232
TABLE 249 INDIA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 250 INDIA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 251 INDIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 234
TABLE 252 INDIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 234
TABLE 253 AUSTRALIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 236
TABLE 254 AUSTRALIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 236
TABLE 255 AUSTRALIA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 256 AUSTRALIA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 257 AUSTRALIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 238
TABLE 258 AUSTRALIA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 238
TABLE 259 SOUTH KOREA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 239
TABLE 260 SOUTH KOREA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 240
TABLE 261 SOUTH KOREA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 262 SOUTH KOREA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 263 SOUTH KOREA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 241
TABLE 264 SOUTH KOREA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 242
TABLE 265 REST OF ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 243
TABLE 266 REST OF ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 243
TABLE 267 REST OF ASIA PACIFIC: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 268 REST OF ASIA PACIFIC: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 269 REST OF ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245
TABLE 270 REST OF ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 245
TABLE 271 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 246
TABLE 272 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 247
TABLE 273 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 247
TABLE 274 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 248
TABLE 275 LATIN AMERICA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 248
TABLE 276 LATIN AMERICA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 277 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 249
TABLE 278 LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 250
TABLE 279 BRAZIL: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 251
TABLE 280 BRAZIL: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2023–2030 (USD MILLION) 251
TABLE 281 BRAZIL: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 282 BRAZIL: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 252
TABLE 283 BRAZIL: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 253
TABLE 284 BRAZIL: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 253
TABLE 285 MEXICO: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 254
TABLE 286 MEXICO: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 255
TABLE 287 MEXICO: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 255
TABLE 288 MEXICO: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 256
TABLE 289 MEXICO: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 256
TABLE 290 MEXICO: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 257
TABLE 291 REST OF LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 258
TABLE 292 REST OF LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 258
TABLE 293 REST OF LATIN AMERICA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 294 REST OF LATIN AMERICA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 295 REST OF LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 260
TABLE 296 REST OF LATIN AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 260
TABLE 297 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 261
TABLE 298 MIDDLE EAST & AFRICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 262
TABLE 299 MIDDLE EAST & AFRICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TREATMENT, 2023–2030 (USD MILLION) 262
TABLE 300 MIDDLE EAST & AFRICA: SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 301 MIDDLE EAST & AFRICA: NON-SURGICAL PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 302 MIDDLE EAST & AFRICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 264
TABLE 303 MIDDLE EAST & AFRICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET, BY END USER, 2023–2030 (USD MILLION) 264
TABLE 304 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 266
TABLE 305 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET:
DEGREE OF COMPETITION 268
TABLE 306 REGION FOOTPRINT 272
TABLE 307 PRODUCT FOOTPRINT 273
TABLE 308 TREATMENT FOOTPRINT 274
TABLE 309 APPLICATION FOOTPRINT 274
TABLE 310 LIST OF START-UPS/SMES 277
TABLE 311 COMPETITIVE BENCHMARKING OF START-UPS/SMES 278
TABLE 312 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET:
PRODUCT LAUNCHES/APPROVALS, 2022–2025 281
TABLE 313 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET:
DEALS, 2022–2025 282
TABLE 314 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET:
OTHER DEVELOPMENTS, 2022–2025 283
TABLE 315 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 284
TABLE 316 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 285
TABLE 317 BOSTON SCIENTIFIC CORPORATION: DEALS 286
TABLE 318 COLOPLAST GROUP: COMPANY OVERVIEW 287
TABLE 319 COLOPLAST GROUP: PRODUCTS OFFERED 289
TABLE 320 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY OVERVIEW 290
TABLE 321 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCTS OFFERED 291
TABLE 322 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCT LAUNCHES/APPROVALS 292
TABLE 323 COOPERCOMPANIES: COMPANY OVERVIEW 293
TABLE 324 COOPERCOMPANIES: PRODUCTS OFFERED 294
TABLE 325 COOPERCOMPANIES: DEALS 295
TABLE 326 JOHNSON & JOHNSON: COMPANY OVERVIEW 296
TABLE 327 JOHNSON & JOHNSON: PRODUCTS OFFERED 297
TABLE 328 JOHNSON & JOHNSON: PRODUCT LAUNCHES/APPROVALS 298
TABLE 329 JOHNSON & JOHNSON: DEALS 298
TABLE 330 JOHNSON & JOHNSON: OTHER DEVELOPMENTS 298
TABLE 331 GE HEALTHCARE: COMPANY OVERVIEW 300
TABLE 332 GE HEALTHCARE: PRODUCTS OFFERED 301
TABLE 333 GE HEALTHCARE: PRODUCT LAUNCHES/APPROVALS 302
TABLE 334 GE HEALTHCARE: DEALS 302
TABLE 335 GE HEALTHCARE: OTHER DEVELOPMENTS 302
TABLE 336 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 303
TABLE 337 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 304
TABLE 338 B. BRAUN SE: COMPANY OVERVIEW 305
TABLE 339 B. BRAUN SE: PRODUCTS OFFERED 306
TABLE 340 B. BRAUN SE: DEALS 307
TABLE 341 PFM MEDICAL GMBH: COMPANY OVERVIEW 308
TABLE 342 PFM MEDICAL GMBH: PRODUCTS OFFERED 308
TABLE 343 CALDERA MEDICAL: COMPANY OVERVIEW 309
TABLE 344 CALDERA MEDICAL: PRODUCTS OFFERED 309
TABLE 345 CALDERA MEDICAL: DEALS 310
FIGURE 1 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET SEGMENTATION 31
FIGURE 2 RESEARCH DESIGN 34
FIGURE 3 TOP-DOWN APPROACH 41
FIGURE 4 DATA TRIANGULATION 42
FIGURE 5 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY PRODUCT, 2025 VS. 2030 (USD MILLION) 45
FIGURE 6 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY TREATMENT, 2025 VS. 2030 (USD MILLION) 46
FIGURE 7 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY APPLICATION, 2025 VS. 2030 (USD MILLION) 47
FIGURE 8 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET,
BY END USER, 2025 VS. 2030 (USD MILLION) 48
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET 49
FIGURE 10 RISE IN FEMALE GERIATRIC POPULATION TO DRIVE MARKET 51
FIGURE 11 HOSPITALS AND CHINA ACCOUNTED FOR SIGNIFICANT SHARES IN 2024 52
FIGURE 12 ASIA PACIFIC TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 53
FIGURE 13 INDIA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 54
FIGURE 14 PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET DYNAMICS 55
FIGURE 15 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 61
FIGURE 16 VALUE CHAIN ANALYSIS 64
FIGURE 17 SUPPLY CHAIN ANALYSIS 65
FIGURE 18 ECOSYSTEM ANALYSIS 66
FIGURE 19 INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION) 67
FIGURE 20 PATENT ANALYSIS 70
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS 80
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR PRODUCTS 82
FIGURE 23 KEY BUYING CRITERIA FOR TOP FOUR PRODUCTS 83
FIGURE 24 IMPACT OF AI ON PELVIC ORGAN PROLAPSE/PELVIC FLOOR
RECONSTRUCTION MARKET 85
FIGURE 25 NORTH AMERICA: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET SNAPSHOT 180
FIGURE 26 ASIA PACIFIC: PELVIC ORGAN PROLAPSE/PELVIC FLOOR RECONSTRUCTION MARKET SNAPSHOT 219
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 267
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 268
FIGURE 29 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 271
FIGURE 30 COMPANY FOOTPRINT 272
FIGURE 31 COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024 276
FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK
BETA OF KEY VENDORS 279
FIGURE 33 EV/EBITDA OF KEY VENDORS 280
FIGURE 34 BRAND/PRODUCT COMPARATIVE ANALYSIS 280
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 285
FIGURE 36 COLOPLAST GROUP: COMPANY SNAPSHOT 288
FIGURE 37 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY SNAPSHOT 291
FIGURE 38 COOPERCOMPANIES: COMPANY SNAPSHOT 294
FIGURE 39 JOHNSON & JOHNSON: COMPANY SNAPSHOT 297
FIGURE 40 GE HEALTHCARE: COMPANY SNAPSHOT 301
FIGURE 41 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT 304
FIGURE 42 B. BRAUN SE: COMPANY SNAPSHOT 306